testosterone cypionate,arv-471,zanubrutinib,selumetinib
beigene,spdr s&p biotech,pfizer,mirati,onconova therapuetics,arvinas,legend biotech,ishares biotechnology,merck,inovio pharmaceuticals,seres therapeutics,immunic therapeutics,astrazeneca
['koselugo', 'brukinsa', 'derm', 'arv-471', 'depo', 'zanubrutinib', 'molecular,partners', 'legend bio', 'immunic', ' arvinas ', 'pfizer', 'beigene', '$imux', 'onconova', 'mirati', '$ibb', '$ino', '$xbi', 'seres therap']
biotech stock news 5/8 $xbi $84.5 (-1.0%) $ibb $130.4 (-1.2%) $trvn 373% approval of olinvyk in china
$inmb 8% ind cleared
$imux 6% data presented '23
$rxrx 6% to acquire cyclica &amp; valence
$gkos 5% nda accepted; pdufa set
$kdny 4% upcoming presentation '23
$ino 2% 
Catalyst Calendar, Big Mover stocks to watch, & model portfolios. Database & tools to help with your biotech stock research. not investment advice. https://t.co/5njnanqtbK